Clinical Trial Update: Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Acthar (repository corticotropin injection) in diabetic nephropathy with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED | Results posted: 2017-07-24